These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17445207)

  • 21. PARK2 and proinflammatory/anti-inflammatory cytokine gene interactions contribute to the susceptibility to leprosy: a case-control study of North Indian population.
    Chopra R; Kalaiarasan P; Ali S; Srivastava AK; Aggarwal S; Garg VK; Bhattacharya SN; Bamezai RN
    BMJ Open; 2014 Feb; 4(2):e004239. PubMed ID: 24578538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia.
    Agirre X; Román-Gómez J; Vázquez I; Jiménez-Velasco A; Garate L; Montiel-Duarte C; Artieda P; Cordeu L; Lahortiga I; Calasanz MJ; Heiniger A; Torres A; Minna JD; Prósper F
    Int J Cancer; 2006 Apr; 118(8):1945-53. PubMed ID: 16287063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunogenetics of leprosy].
    Lagrange PH
    Acta Leprol; 1986; 4(3):303-22. PubMed ID: 3551470
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetics of leprosy.
    Schurr E; Morgan K; Gros P; Skamene E
    Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):4-11. PubMed ID: 1904201
    [No Abstract]   [Full Text] [Related]  

  • 25. HLA and sporadic tuberculoid leprosy: a population study in Maharashtra, India.
    van Eden W; Mehra NK; Vaidya MC; D'Amaro J; Schreuder GM; van Rood JJ
    Tissue Antigens; 1981 Sep; 18(3):189-94. PubMed ID: 7336423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic control of innate resistance to mycobacterial infections.
    Schurr E; Malo D; Radzioch D; Buschman E; Morgan K; Gros P; Skamene E
    Immunol Today; 1991 Mar; 12(3):A42-5. PubMed ID: 2069678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the genetic basis of susceptibility to mycobacterial infection.
    Levin M; Newport M
    Proc Assoc Am Physicians; 1999; 111(4):308-12. PubMed ID: 10417738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leprosy pathogenetic background: a review and lessons from other mycobacterial diseases.
    Goulart LR; Goulart IM
    Arch Dermatol Res; 2009 Feb; 301(2):123-37. PubMed ID: 19043725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility to mycobacterial infections: the importance of host genetics.
    Bellamy R
    Genes Immun; 2003 Jan; 4(1):4-11. PubMed ID: 12595896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host genetics in susceptibility to and severity of mycobacterial diseases.
    Apt AS; Logunova NN; Kondratieva TK
    Tuberculosis (Edinb); 2017 Sep; 106():1-8. PubMed ID: 28802396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host genetic factors and mycobacterial infections: lessons from single gene disorders affecting innate and adaptive immunity.
    Doffinger R; Patel SY; Kumararatne DS
    Microbes Infect; 2006 Apr; 8(4):1141-50. PubMed ID: 16520078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic predisposition and susceptibility to mycobacterial infections: the IL-12-IFNgamma axis deficiency].
    Picard C; Casanova JL
    Rev Med Brux; 2005 Feb; 26(1):17-9. PubMed ID: 15816335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mendelian susceptibility to mycobacterial disease.
    Cottle LE
    Clin Genet; 2011 Jan; 79(1):17-22. PubMed ID: 20718793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stepwise replication identifies a low-producing lymphotoxin-alpha allele as a major risk factor for early-onset leprosy.
    Alcaïs A; Alter A; Antoni G; Orlova M; Nguyen VT; Singh M; Vanderborght PR; Katoch K; Mira MT; Vu HT; Ngyuen TH; Nguyen NB; Moraes M; Mehra N; Schurr E; Abel L
    Nat Genet; 2007 Apr; 39(4):517-22. PubMed ID: 17353895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion of the parkin and PACRG gene promoter in early-onset parkinsonism.
    Lesage S; Magali P; Lohmann E; Lacomblez L; Teive H; Janin S; Cousin PY; Dürr A; Brice A;
    Hum Mutat; 2007 Jan; 28(1):27-32. PubMed ID: 17068781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae.
    van de Vosse E; Hoeve MA; Ottenhoff TH
    Lancet Infect Dis; 2004 Dec; 4(12):739-49. PubMed ID: 15567123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic susceptibility to mycobacterial disease in humans.
    Fernando SL; Britton WJ
    Immunol Cell Biol; 2006 Apr; 84(2):125-37. PubMed ID: 16519730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introduction: new susceptibility genes in mycobacterial infectious diseases.
    Ottenhoff TH
    Microbes Infect; 2006 Apr; 8(4):1117-8. PubMed ID: 16517199
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic dissection of immunity to mycobacteria: the human model.
    Casanova JL; Abel L
    Annu Rev Immunol; 2002; 20():581-620. PubMed ID: 11861613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome.
    Cardoso CC; Pereira AC; de Sales Marques C; Moraes MO
    Future Microbiol; 2011 May; 6(5):533-49. PubMed ID: 21585261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.